To determine the effect of FOLFOX on the anti-tumor immune response, we used a murine CRC cell line expressing the model antigen Carcinoembryonic Antigen (MC38-CEA2) (31) to track tumor antigen specific CD8 T cell immunity. Here, CD8A is linked to colorectal carcinoma.